1. Home
  2. VERA vs RAMP Comparison

VERA vs RAMP Comparison

Compare VERA & RAMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • RAMP
  • Stock Information
  • Founded
  • VERA 2016
  • RAMP 2018
  • Country
  • VERA United States
  • RAMP United States
  • Employees
  • VERA N/A
  • RAMP N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • RAMP EDP Services
  • Sector
  • VERA Health Care
  • RAMP Technology
  • Exchange
  • VERA Nasdaq
  • RAMP Nasdaq
  • Market Cap
  • VERA 1.4B
  • RAMP 1.8B
  • IPO Year
  • VERA 2021
  • RAMP 1987
  • Fundamental
  • Price
  • VERA $24.98
  • RAMP $27.14
  • Analyst Decision
  • VERA Buy
  • RAMP Buy
  • Analyst Count
  • VERA 8
  • RAMP 7
  • Target Price
  • VERA $64.29
  • RAMP $39.00
  • AVG Volume (30 Days)
  • VERA 1.8M
  • RAMP 620.0K
  • Earning Date
  • VERA 11-06-2025
  • RAMP 11-05-2025
  • Dividend Yield
  • VERA N/A
  • RAMP N/A
  • EPS Growth
  • VERA N/A
  • RAMP 147.00
  • EPS
  • VERA N/A
  • RAMP 0.22
  • Revenue
  • VERA N/A
  • RAMP $764,441,000.00
  • Revenue This Year
  • VERA N/A
  • RAMP $10.65
  • Revenue Next Year
  • VERA N/A
  • RAMP $8.70
  • P/E Ratio
  • VERA N/A
  • RAMP $123.53
  • Revenue Growth
  • VERA N/A
  • RAMP 12.16
  • 52 Week Low
  • VERA $18.53
  • RAMP $22.82
  • 52 Week High
  • VERA $51.61
  • RAMP $36.08
  • Technical
  • Relative Strength Index (RSI)
  • VERA 61.01
  • RAMP 45.80
  • Support Level
  • VERA $22.72
  • RAMP $26.15
  • Resistance Level
  • VERA $25.29
  • RAMP $27.08
  • Average True Range (ATR)
  • VERA 1.19
  • RAMP 0.66
  • MACD
  • VERA 0.13
  • RAMP 0.10
  • Stochastic Oscillator
  • VERA 87.80
  • RAMP 38.37

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About RAMP LiveRamp Holdings Inc.

LiveRamp Holdings Inc is a global technology company that helps companies build enduring brand and business value by collaborating responsibly with data. A groundbreaking leader in consumer privacy, data ethics and foundational identity, LiveRamp offers a connected customer view with clarity and context while protecting brand and consumer trust.

Share on Social Networks: